Members of the genus Streptomyces are filamentous soil bacteria which produce a wide array of secondary natural products, many of which are useful therapeutic agents (11) . These bacteria also possess a complex life cycle that requires temporal differentation of morphology and physiology (9, 24) . Little is known about the regulation of the processes involved in Streptomyces differentation, but it is clear that a better understanding of the regulation of antibiotic production genes at the molecular level would provide insight into the fundamental issue of temporal regulation of differentation and secondary metabolism in Streptomyces spp. This knowledge in turn should facilitate efforts to engineer strains that overproduce valuable microbial metabolites.
We have been engaged in a study of the molecular biology of daunorubicin (DNR) biosynthesis, resistance, and regulation in Streptomyces peucetius ATCC 29050. DNR and doxorubicin (14-hydroxy-DNR) ( Fig. 1 ) are commercially important chemotherapeutic agents, and their study has proved to be a useful vehicle with which to address fundamental issues of Streptomyces molecular biology.
Previous reports from this laboratory (35, 43) have demonstrated that the DNR producer S. peucetius possesses two DNA segments of approximately 2 kb, dnrR 1 and dnrR 2 , both of which restore DNR production to a putative regulatory mutant (S. peucetius H6101) even though the two segments are separated from each other by approximately 12.4 kb (43) . These two DNA fragments also caused overproduction of DNR and ε-rhodomycinone (RHO), an intermediate of DNR biosynthesis ( Fig. 1) , when introduced into wild-type and mutant strains (43) . In addition, only the dnrR 2 segment conferred high-level DNR resistance to the H6101 self-sensitive mutant (43) . These results suggested that the dnrR 1 and dnrR 2 loci may be involved in the regulation of DNR biosynthesis. Sequence analysis of the dnrR 1 fragment (43) and subsequent inactivation of the dnrI and dnrJ genes contained within it have supported the conclusion that dnrI is involved in the transcriptional activation of DNR biosynthesis genes, as described in the accompanying paper by Madduri and Hutchinson (30) . Here we report the sequence analysis of the dnrR 2 locus, which contains two divergently transcribed open reading frames (ORFs), dnrN and dnrO. We also describe the results of expression of the dnrN and dnrO genes in wild-type and mutant strains and the effects of insertional inactivation and amino acid substitutions at the putative site of phosphorylation on the activity of DnrN. These data are utilized to provide evidence to support the conclusion that dnrN encodes a response regulator of the UhpA-LuxR superfamily of regulatory proteins (19) and that dnrO encodes a possible repressor.
MATERIALS AND METHODS
Biochemicals and chemicals. DNR, 14-hydroxy-DNR, carminomycin, and RHO were obtained from Pharmacia-Farmitalia Carlo Erba (Milan, Italy). Apramycin was obtained from Gene Seno at Eli Lilly & Co. (Indianapolis, Ind.). Thiostrepton was obtained from Sal Lucania at E. R. Squibb & Sons (Princeton, N.J.). Restriction enzymes and other molecular biology reagents were obtained from standard commercial sources.
Bacterial strains and plasmids. S. peucetius ATCC 29050 was obtained from the American Type Culture Collection (Rockville, Md.). S. peucetius subsp. caesius H6101 and H6125 (21, 22) were obtained from Ho Coy-Choke (University of Malaya, Kuala Lumpur, Malaysia). Escherichia coli DH5␣ and JM105 (38) were used for subcloning and single-stranded DNA preparation. The cosmid cloning vector pKC505 (36) was obtained from Richard Baltz (Eli Lilly & Co.). The Streptomyces plasmid pIJ702 (29) was obtained from David Hopwood (John Innes Institute, Norwich, United Kingdom). The high-copy-number Streptomyces shuttle vector pWHM3 was from Vara et al. (46) , and the low-copy-number shuttle vector pWHM601 was from Guilfoile and Hutchinson (17) . The pUC4-KIXX plasmid containing the neomycin-kanamycin resistance gene (aphII) from Tn5 was obtained from Pharmacia (Piscataway, N.J.). The single-stranded DNA integration vector pDH5 was obtained from W. Wohlleben (Universität Bielefeld, Bielefeld, Germany). The helper phage R408 used for the isolation of single-stranded DNA was obtained from Promega Corp. (Madison, Wis.).
Media and growth conditions. Streptomyces strains were grown for 7 to 10 days at 30ЊC on ISP medium 4 (Difco Laboratories, Detroit, Mich.) for spore preparation and at 30ЊC in R2YE medium (25) for preparation of protoplasts and isolation of chromosomal and plasmid DNAs. E. coli strains were grown in LB medium (38) at 37ЊC. Plasmid-containing Streptomyces strains were selected with 10 g of thiostrepton per ml, 25 g of apramycin per ml, or 50 g of neomycin per ml, and E. coli strains were selected with 100 g of ampicillin per ml, 100 g of apramycin per ml, or 50 g of neomycin per ml. E. coli strains containing M13 were grown in 2ϫ YT medium (38) for preparation of single-stranded DNA. For the determination of anthracycline production, S. peucetius strains were grown in the APM seed medium as previously described (17) except that the MOPS (morpholinepropanesulfonic acid) concentration was 10 g/liter. Seed cultures were inoculated with mycelium from ISP4 plates and incubated for 1 day for S. peucetius ATCC 29050 and 2 days for the H6101 and H6125 strains. The seed culture was transferred to 25 ml of the GPS complex production medium used by Dekleva et al. (12) and incubated at 30ЊC for 72 h. After acidification with oxalic acid and heating at 60ЊC for 45 min, the cultures were adjusted to pH 8.5 and extracted with chloroform (42) . Anthracycline production was determined by high-pressure liquid chromatography (HPLC) analysis as previously described (35) . The DNR resistance of S. peucetius strains was determined as previously described (35) . Cultures for bioconversion experiments were grown as described above for anthracycline production except that after 24 h of incubation in production medium, a substrate (RHO, carminomycin, or DNR) was added to a final concentration of 10 g/ml. The cultures were incubated for an additional 48 h and were then extracted and analyzed by HPLC as described above.
DNA sequencing. DNA fragments were subcloned into M13mp18 and M13mp19, and the single-stranded DNA templates were sequenced by the dideoxynucleotide chain termination method with ␣-35 S-dCTP and Sequenase 2.0 (U.S. Biochemicals, Cleveland, Ohio) according to the manufacturer's instructions. Sequencing reactions were carried out with 7-deaza-dGTP in order to reduce compressions.
Southern analysis. Chromosomal DNA was digested with restriction enzymes for 6 h, electrophoresed in a 0.7% agarose gel overnight, and blotted to Hybond N (Amersham, Arlington Heights, Ill.) by capillary transfer (38) . Labeling, hybridization, and detection were carried out with the Genius 1 kit (Boehringer Mannheim, Indianapolis, Ind.) according to the manufacturer's instructions and under standard conditions.
Mutagenesis of aspartate 55 of DnrN. Synthetic linkers were used to replace the aspartate (D) residue at position 55 (GAT) of dnrN with glutamate (E) (GAG) or asparagine (N) (AAC). The glutamate-generating linker extended from the NcoI site to the ClaI site, and the asparagine-generating linker extended from the SalI site to the BspEI site (Fig. 2) . The corresponding nucleotides in dnrN subcloned in pUC19 (pWHM537) were replaced with the mutagenic linkers by using standard cloning techniques. The mutant dnrN-D55E and -D55N genes were transferred to the low-copy-number shuttle vector pWHM601 to give pWHM541 and pWHM542, respectively. The construction of mutant plasmids was verified by the loss of the unique ClaI site that includes the wild-type D codon (GAT) and by DNA sequencing.
Nucleotide sequence accession number. The nucleotide sequence reported here has been assigned GenBank/EMBL accession number L37338.
RESULTS
Sequence analysis of dnrR 2 . DNA sequencing of both strands of the 1,846-nucleotide (nt) dnrR 2 BamHI fragment ( Fig. 2 ) revealed two divergently transcribed ORFs, dnrN and dnrO, by CODONPREFERENCE analysis (13) . The most likely start codon for dnrN is located at nt 651 (ATG), with a TGA stop codon at position 43, which suggests that this ORF would encode a polypeptide having 202 amino acid residues, an M r of 22,016, and an isoelectric point of 5.43. The start codon is preceded by a probable ribosome binding site, GAAGG, at position 662 that displays significant complementarity to the 3Ј end of Streptomyces lividans 16S rRNA (5Ј-ACCUCCUUUCU-OH-3Ј) (2) . The dnrO gene is transcribed in the direction opposite from that for dnrN and extends 257 nt into the adjacent 0.6-kb BamHI fragment. The dnrO gene has a probable start codon (ATG) at nt 1085 and a TGA stop codon at position 2107. This ORF would encode a polypeptide composed of 340 amino acid residues with an M r of 37,833 and an isoelectric point of 10.09. The dnrO start codon is preceded by a probable ribosome binding site (TGGA) at nt 1078. The 5Ј ends of dnrN and dnrO are separated by a 433-nt intergenetic region lacking the distinctive codon usage and thirdposition GϩC bias characteristic of Streptomyces genes (3).
Characteristics of the deduced products of dnrN and dnrO. Computer analysis of the deduced protein product of dnrN with the TFASTA and FASTA programs (13) identified a number of response regulator proteins having significant similarity to dnrN (Fig. 3) . Response regulator proteins control the adaptive response in two-component regulatory systems (16, 40) and are characterized by an N-terminal response regulator domain containing three highly conserved residues that are believed to compose the active site, with phosphorylation occurring at the second aspartate residue (16, 40) . These residues 
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STREPTOMYCES PEUCETIUS dnrNO GENES 1217 are conserved in dnrN except for the conservative substitution of glutamate for the aspartate residue closest to the N-terminal end (Fig. 3) . The residues which make up the hydrophobic core have also been shown to be conserved among all response regulators (16, 40) , and these residues are highly conserved in dnrN as well. Response regulators can be further categorized into subfamilies on the basis of conservation of the C-terminal domains which generally control the adaptive response (16, 40) . The dnrN gene is clearly a member of the UhpA subfamily (40) and shows significant sequence similarity in the region of the putative helix-turn-helix DNA binding motif (37, 47) , which is a characteristic of the proteins in this family. The deduced dnrO protein was found to have substantial similarity to the Streptomyces glaucescens tetracenomycin C resistance gene repressor (TcmR) (18) and to two E. coli repressors, the biotin operon repressor (BirA) (8) and the tetracycline resistance gene repressor (TetR) (45) (Fig. 4) . A significant feature is the conservation of amino acid sequence in the N-terminal region which has been defined as the DNAbinding domain of BirA (48) and is characterized by the presence of a helix-turn-helix motif (5) that is involved in binding to the 40-bp bio operator (1) .
Expression of dnrN in S. peucetius strains. The dnrN gene was subcloned as a 1.1-kb BamHI-SphI fragment into the lowcopy-number vector pWHM601 (as pWHM533) and the highcopy-number-vector pWHM3 (as pWHM534). These plasmids were introduced by transformation into S. peucetius ATCC 29050, the H6101 strain (a putative regulatory mutant), and the H6125 strain (a blocked mutant that accumulates RHO). Three transformants of each strain were analyzed for production of RHO and DNR (Fig. 5) . The dnrN gene restored DNR production in H6101, and when present in high copy number (pWHM534) resulted in typical wild-type levels of RHO and DNR. The dnrN gene also increased RHO production (2-to 15-fold) in H6125 and increased production of both RHO (2-to 4-fold) and DNR (2-to 2.5-fold) in the wild-type strain. An apparent copy number effect was observed with dnrN (Fig. 5) . The partial dnrO gene contained within the dnrR 2 locus was also subcloned into pWHM601 and pWHM3, and the effect of dnrO on anthracycline production was tested in the same manner as for dnrN. The partial dnrO gene caused a slight decrease in antibiotic production or had no effect in the S. peucetius strains tested (data not shown). These results indicate that the dnrN gene is responsible for the effects observed with dnrR 2 (43) , which contains dnrN and part of dnrO.
Insertional inactivation and gene replacement of dnrN in S. peucetius ATCC 29050. The dnrN gene was inactivated by insertion of the kanamycin resistance gene as a 1.6-kb XhoI fragment into a unique SalI site near the beginning of the dnrN (Fig. 6 ). S. peucetius ATCC 29050 was transformed with the single-stranded plasmid containing the disrupted dnrN gene, and transformants were selected with thiostrepton (10 g/ml) or neomycin (50 g/ml). Transformants were patched on ISP4 plates containing thiostrepton (10 g/ml) or neomycin (50 g/ml) to verify integration of the plasmid. One of these transformants was subjected to two The probe hybridized to a 3.5-kb fragment for the dnrN::aphII strain, which is consistent with the insertion of the 1.6-kb kanamycin resistance gene into the dnrN gene. The wild-type and H6101 strains showed the expected 1.9-kb dnrN fragment. The WMH1530 strain produced no identifiable anthracycline products and was unable to bioconvert RHO, carminomycin, or DNR. The dnrN::aphII mutation in WHM1530 could be complemented by dnrN cloned on pWHM601 as pWHM533, to give 16.5 Ϯ 1.54 g of RHO per ml and 2.6 Ϯ 0.47 g of DNR per ml. These values are approximately twofold less than those obtained with the wild-type strain transformed with the vector alone. In addition, the DNR resistance of the dnrN::aphII strain was only to 200 g/ml which is at least a 2.5-fold reduction relative to the wild-type strain. Low-resolution S1 protection analysis has shown that the transcripts coding for the putative DNR resistance proteins DrrA (17), DrrB (17) , and DrrC (23) are absent in the dnrN::aphII strain (30) . These data together show that the inactivation of dnrN results in the loss of a number of enzymatic activities involved in DNR biosynthesis and demonstrate the absence of mRNA transcripts, which is consistent with the identification of dnrN as a response regulator on the basis of sequence similarities.
Amino acid substitution for aspartate 55 of DnrN. On the basis of similarities between the deduced amino acid sequence of the N-terminal domain of dnrN and other response regulators (16, 40) , the putative site of phosphorylation of DnrN appears to be the aspartate residue at position 55 (D-55). In order to examine the role of D-55 in DnrN function, two amino acid substitutions, glutamate (E) and asparagine (N), were made at this position. The mutant dnrN-D55E and -D55N genes carried on the low-copy-number vector pWHM601 (pWHM541 and pWHM542, respectively) were examined for their abilities to confer RHO and DNR production to the nonproducing dnrN::aphII mutant strain (WHM1530). Interestingly, both dnrN-D55E and -D55N resulted in significant levels of RHO and DNR production relative to those with the wild-type dnrN gene in the same vector (53% for dnrN-D55E [n ϭ 5] and 35% for dnrN-D55N [n ϭ 4]). These data demonstrate that the D-55 residue is important but not essential for DnrN activity. Similar amino acid substitutions at the putative site of phosphorylation have been made in other response regulators and have generally resulted in the loss of function (see, e.g., references 4, 6, and 44); however, there have been exceptions in which the variant protein retained significant activity (7, 33) . Since these exceptions involve analogous amino acid substitutions in proteins for which the requirement and site of phosphorylation have been convincingly established (e.g., nitrogen regulator I [NR I or NtrC] [33] ), the significance of the results from DnrN-D55E and -D55N remains uncertain at this time.
Suppression of the dnrN::aphII mutation by dnrR 1 . The dnrN::aphII strain was transformed with the 2-kb BamHI dnrIJ segment cloned in pIJ702 and pKC505 (43) , and the dnrI::aphII strain, a dnrIJ mutant (43) , was transformed with the 1.9-kb BamHI dnrNO segment cloned in pWHM601 and pWHM3 to determine if these loci could compensate for each other. The results showed that the dnrNO genes carried on low-or high-copy-number vectors could not restore production of RHO in the dnrIJ::aphII strain (RHO would be the expected product, since dnrJ is required for conversion of RHO to DNR) (30) . However, the dnrN::aphII mutation was suppressed by the dnrIJ genes carried on a high-copy-number vector (pIJ702), to give 89.6 Ϯ 11.51 g of RHO per ml and 1.6 Ϯ 0.12 g of DNR per ml. These values were approximately 10-fold less that those obtained with the wild-type strain containing the same plasmid (43) . In addition, low-resolution S1 nuclease protection experiments have shown that the dnrI transcript is not present in the dnrN::aphII strain (30) . These results indicate that dnrN is epistatic to dnrI and that sufficient 
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on February 21, 2013 by PENN STATE UNIV http://jb.asm.org/ dnrI can be expressed from a high-copy-number vector to activate the DNR pathway in the absence of DnrN.
DISCUSSION
The dnrN gene clearly appears to be a response regulator on the basis of the conservation of the deduced amino acid sequence relative to those of known response regulators and the properties of the dnrN::aphII mutant, which include the loss of DNR production, a decrease in DNR resistance, the inability to bioconvert intermediates of DNR biosynthesis, and the absence of the four dnr gene transcripts that have been investigated thus far (30) . Antibiotic production in Streptomyces coelicolor also appears to be under the influence of two-component regulatory systems. These include the afsRK (26, 31) and the afsQ 1 Q 2 (28) genes. However, these systems differ from dnrN in that antibiotic production is not completely abolished by loss-of-function mutations in afsR (26) or afsK (31) and is not affected by disruption of afsQ 1 and afsQ 2 (28) .
The dnrN gene appears to be required for the transcription of dnrI, since the dnrI transcript is absent in the dnrN::aphII mutant (30) . Furthermore, the finding that the dnrIJ genes can suppress the dnrN::aphII mutation is consistent with the conclusion that dnrI is required for transcription of most if not all DNR biosynthesis genes. This conclusion has been supported by the absence of many of the dnr gene transcripts in the dnrI::aphII strain (30) . Consequently, these data suggest the presence of a regulatory cascade in which dnrN activates the transcription of dnrI, which in turn activates transcription of the DNR biosynthesis genes. In light of these results, the putative regulatory mutant, S. peucetius H6101, could be viewed as a dnrN mutant (due to a mutation in the dnrN gene itself or a gene required for dnrN expression), which would be consistent with most of the observed characteristics of this strain (35, 43) .
Interestingly, the dnrN::aphII and dnrI::aphII strains still possess significant levels of DNR resistance, i.e., 200 and 100 g/ml, respectively, compared with Ն500 g/ml for the wildtype strain. In the case of the dnrN::aphII mutant, it is conceivable that this DNR resistance results from low-level transcription of dnrI. However, in the case of the dnrI::aphII strain, the nature of the mutation and the observed properties of the strain seem to exclude the possibility that any functional DnrI protein could be present (30, 43) . This implies that S. peucetius possesses some mechanism of DNR resistance that can be expressed independently from dnrI, such as the DNR resistance genes identified by Colombo et al. (10) , which are different from the drrAB (17) and drrC (23) resistance genes and lie outside the gene cluster containing dnrN and dnrI. The fact that the introduction of extra copies of dnrN carried on a high-copy-number plasmid results in a twofold increase in the DNR resistance of the dnrI::aphII mutant (34) implies that dnrN may be able to influence the expression of DNR resistance by some mechanism which does not require DnrI. These observations raise the possibility that the dnr regulatory circuit may well be more complex than the current working model (Fig. 7) .
The intergenetic region between dnrN and dnrO contains a number of sequence motifs with possible regulatory functions that warrant further investigation (Fig. 2) . For example, the probable start codon for dnrO is preceded by a potential promoter region with characteristics of Streptomyces promoters that have significant similarity to those recognized by E. coli E 70 -like RNA polymerases (41) , and this potential promoter is overlapped by an imperfect 17-nt inverted repeat. Other notable features include a set of three 11-nt perfect (with the exception of the last nucleotide of the third repeat) direct repeats, which can also be represented as two perfect overlapping 21-nt direct repeats, and the presence of two overlapping potential promoter regions preceding the coding region for dnrN.
DnrN would be expected to require a histidine kinase to convert it to the active phosphorylated form, as is the case for other bacterial response regulators (40) . Typically the histidine kinase gene is located in close proximity to the response regulator gene; however, sequence analysis of the apparent dnr gene cluster (27) has not led to the identification of a gene whose deduced product has the characteristics of known bacterial histidine kinases (40) . This suggests several possibilities: the dnr cluster may extend beyond the region that has been defined (27) , the putative histidine kinase may be located outside the dnr cluster, or dnrN may not require a histidine kinase. None of these possibilities can be excluded at this time.
The fact that the D55E and D55N amino acid substitutions at the putative site of phosphorylation did not abolish DnrN activity is seemingly inconsistent with the conventional model, in which phosphorylation is required to regulate the activity of response regulators. There are many reports of similar amino acid substitutions at the predicted site of phosphorylation that have resulted in the loss of function; however, there are some notable exceptions. One of these is the substitution of glutamate for aspartate 54 (D54E) of NR I (33) . Cells containing NR I -D54E produced glutamine synthetase and were Ntr ϩ . In addition, it has been shown that the OmpR-D55Q mutation, which results in the complete loss of OmpR function (6), can be suppressed by second-site mutations which replace threonine 83 with alanine (T83A) or glycine 94 with serine (G94S) (7) . From the sequence similarities between the N-terminal domains of OmpR and DnrN, T-83 and G-94 of OmpR would be expected to correspond to A-83 and S-94 of DnrN, which suggests that DnrN may contain nonconsensus amino acid residues that correspond to the second-site suppressors of OmpR-D55Q.
It has been proposed that NR I -D54E and OmpR-D55Q-G94S are active because these amino acid substitutions permit FIG. 7 . Hypothetical model for the regulation of DNR biosynthesis in S. peucetius ATCC 29050. The model suggests that transcription of the DNR biosynthesis and resistance genes is controlled by a regulatory cascade in which dnrN activates transcription of dnrI, which in turn activates transcription of the DNR genes. The arrows point to genes whose transcripts are absent when the corresponding regulatory gene has been inactivated (30) . The patterns in the boxes indicate genes with related functions. some portion of the protein molecules to achieve the active conformation in the absence of phosphorylation (7, 33) . This interpretation may be applied to DnrN-D55E and -D55N as well and would suggest that the activity of the D55E and D55N variants of DnrN is a consequence of factors that result in an active conformation in a way which is largely coincidental. If one takes the opposing view that the activity of the DnrN mutants is not coincidental but is derived from features of the protein that play an important role in the function of DnrN, the means by which the activity of DnrN is regulated might be expected to deviate in a significant way from the conventional phosphorylation mechanism. The fact that a putative repressor gene, dnrO, is located adjacent to and transcribed divergently from dnrN provides the possibility that DnrN could be regulated by DnrO at the level of transcription.
At this point it is not possible to distinguish between these two interpretations, and they are both consistent with the available data. These issues warrant further investigation, and future work will be directed towards elucidating the state of phosphorylation of DnrN, the possible significance of the nonconsensus A-83 and S-94 amino acid residues of DnrN, and the function of DnrO. This work should provide valuable insight into the function and regulation of dnrN and its role in the regulation of DNR biosynthesis.
